Derivation and validation of a cardiovascular risk score for prediction of major acute cardiovascular events in non-alcoholic fatty liver disease; the importance of an elevated mean platelet volume-Reference-Cited by-同舟云学术

Derivation and validation of a cardiovascular risk score for prediction of major acute cardiovascular events in non-alcoholic fatty liver disease; the importance of an elevated mean platelet volume

Published:2019-03-05 Issue:8 Volume:49 Page:1077-1085
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Abeles Robin D.¹,Mullish Benjamin H.¹^ORCID,Forlano Roberta¹^ORCID,Kimhofer Torben²,Adler Maciej¹,Tzallas Alexandros³,Giannakeas Nikolaos³,Yee Michael⁴,Mayet Jamil⁵,Goldin Robert D.⁶,Thursz Mark R.¹^ORCID,Manousou Pinelopi¹^ORCID

Affiliation:

1. Liver Unit/ Division of Integrative Systems Medicine and Digestive Disease, Department of Surgery and Cancer; St Mary’s Hospital Campus, Imperial College London; London UK

2. Department of Surgery and Cancer; Centre for Computational and System Medicine, Imperial College London; London UK

3. Department of Computer Engineering, School of Applied Technology; Technological Educational Institute of Epirus; Arta Greece

4. Department of Endocrinology; St Mary’s Hospital, Imperial College Healthcare NHS Trust; London UK

5. National Heart and Lung Institute, Hammersmith Hospital, Imperial College London; London UK

6. Department of Cellular Pathology; St Mary’s Hospital, Imperial College Healthcare NHS Trust; London UK

Funder

EASL

National Institute for Health Research

Medical Research Council

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.15192/fullpdf

Reference54 articles.

1. Significant burden of nonalcoholic fatty liver disease with advanced fibrosis in the US: a cross-sectional analysis of 2011-2014 National Health and Nutrition Examination Survey;Wong;Aliment Pharmacol Ther,2017

2. The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe;Younossi;Hepatology,2016

3. Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis;Targher;J Hepatol,2016

4. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up;Ekstedt;Hepatology,2015

5. General cardiovascular risk profile for use in primary care;D’Agostino;Circulation,2008

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nonalcoholic fatty liver disease is a risk factor for cardiovascular disease;SCIENTIA SINICA Vitae;2024-09-01

2. The Relationship Between the Number of Chronic Diseases and Health-Related Quality of Life Among Middle-Aged and Older Adults in Rural Areas of Yunnan Province, China: moderating Effect of Health Lifestyle;Journal of Multidisciplinary Healthcare;2024-05

3. Platelet, Antiplatelet Therapy and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Narrative Review;Life;2024-04-04

4. The role of platelets in non-alcoholic fatty liver disease: From pathophysiology to therapeutics;Prostaglandins & Other Lipid Mediators;2023-12

5. The relationship between the number of chronic diseases and health-related quality of life among middle-aged and older adults in rural areas of Yunnan province, China: moderating effect of health lifestyle;2023-10-11